IGFBP2 Protein (AA 40-325) (His tag)
Quick Overview for IGFBP2 Protein (AA 40-325) (His tag) (ABIN2017974)
Target
See all IGFBP2 ProteinsProtein Type
Biological Activity
Origin
Source
Purity
-
-
Protein Characteristics
- AA 40-325
-
Purification tag / Conjugate
- This IGFBP2 protein is labelled with His tag.
-
Characteristics
-
ED50 < 2 μg/mL, measured in a bioassay using FDC-P1 cells in the presence of 15 ng/mL human IGF-II.
AA 40-325, expressed with C-terminal 6xHis. -
Endotoxin Level
- < 0.2 EU/μg, determined by LAL method.
-
-
Want other Options for this Protein ?
!Discover Our Predefined Custom Proteins and Custom Protein Services!Your project requires further customization? Contact us and discover our custom protein solutions
-
-
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstituted in ddH2O or PBS at 100 μg/mL.
-
Buffer
- Lyophilized after extensive dialysis against PBS.
-
Storage
- -80 °C
-
Storage Comment
- Lyophilized recombinant human IGF-BP-2, Hisremains stable up to 6 months at -80 °C from date of receipt. Upon reconstitution, human IGF-BP-2, His should be stable up to 1 week at 4 °C or up to 2 months at -20 °C.
-
Expiry Date
- 6 months
-
-
- IGFBP2 (Insulin-Like Growth Factor Binding Protein 2, 36kDa (IGFBP2))
-
Background
-
IGF-BP-2,also known as Insulin-like growth factor-binding protein 2, IBP-2 and BP-2, is a cysteine-rich secreted protein belonging to the IGF-binding protein superfamily. It is expressed by the central nervous system, bone cells and reproductive tissues. IGF-BP-2 binds to both IGF-I and IGF-II, with a much higher binding affinity to IGF-II than IGF-I. IGF-BP-2 has been shown to inhibitand stimulate the growth promoting effects of IGFs, thus serving as a regulator for IGF distribution, function and activity.
Synonyms: Insulin-like growth factor-binding protein 2, IBP-2, BP-2 -
Molecular Weight
- 6-20 kDa, observed by reducing SDS-PAGE.
-
UniProt
- P18065
-
Pathways
- Myometrial Relaxation and Contraction, Growth Factor Binding, Activated T Cell Proliferation
Target
-